Definitive Contract W81XWH18C0077
Award Date 2/22/18
Potential Completion Date 4/30/21
Potential Value $1.5M
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Germany
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to the University of Alabama at Birmingham (UAB). The $2,171,785.57 delivery order supports NIAID protocol #07-0012, a study to enroll male participants and evaluate a treatment for an unspecified infectious disease. The contract does not have a set-aside designation. The contract has two subcontractors: the University of Southern...
- The Defense Health Agency awarded a $11.6 million delivery order against its Medical Product Research and Development master IDIQ contract to PPD Development LP. This cost-plus-fixed-fee order is to provide clinical monitoring services for a Phase 2B proof of concept study being conducted in South Africa. The study aims to develop an HIV vaccine that meets the requirements of the U.S. Military. Performance will take place in South Africa over a five year period concluding in October 2022. No set...
- This is a $417,953.02 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Icon Government and Public Health Solutions, Inc. to execute a clinical trial protocol (NCT02210325). The contract has no set-aside designation. Icon Government and Public Health Solutions, Inc., a global contract research organization, is the prime contractor. It has subcontracted portions of...
- This is a $72,414.00 task order award to The Emmes Company, LLC, a global clinical research organization, to provide regulatory support services for clinical trial testing of a monoclonal antibody (mAb) product to prevent and/or treat HIV. The task order is part of the National Institute of Allergy and Infectious Diseases' (NIAID) Clinical Research Support Services contract, a $545 million Indefinite Delivery Vehicle (IDV) that allows Emmes to provide flexible research support across multiple...
- This federal contract award, valued at $1,920,969.99, was issued by the Defense Health Agency (DHA) to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF), a non-profit organization. The contract is for HIV diagnostics and clinical research, with a period of performance ending on September 29, 2016. It is a definitive contract, with a cost-plus-fixed-fee pricing type. The contract was not set aside for any specific business type. HJF frequently acts as a prime...
- The Department of the Army Medical Command awarded a $18 million Other Transaction Agreement to Janssen Vaccines & Prevention B.V., doing business as JPC, to perform Phase 3 of the HPX3002/HVTN 706/MOSAICO pivotal efficacy study. The study will be conducted in the Netherlands to evaluate Janssen's investigational vaccine for the prevention of HIV-1 infection. As the Army's medical research agency, the Medical Command supports the development and testing of vaccines and therapies through...
- This is a Cost No Fee delivery order contract awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to the University of Alabama at Birmingham (UAB), a public research university. The $1,670,687.20 contract is for the Sexually Transmitted Infections Clinical Trials Group and does not have a set-aside designation. The major subcontractors are The Johns Hopkins University, a private research university, and Family Health International (FHI 360), a...
- This is a cost-plus-fixed-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The contract, with a ceiling value of $86,670,401.90, is for biomedical (advanced) products and services. The prime contractor is Janssen Vaccines & Prevention B.V., a foreign-owned for-profit organization. The contract does not have a set-aside designation and has an ultimate completion date...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $1.21 million delivery order to the University of Nebraska Medical Center (UNMC) on August 1, 2024, for preclinical services supporting HIV therapeutics research. The specific focus is pharmacokinetic/pharmacodynamic (PK/PD) evaluation and assessment of T-5224's effect on HIV-1 transcriptional activity using an HIV-1-mouse model. This delivery order is issued under the "Preclinical Services for HIV...
- This is a $23,855,636.00 Cost Plus Fixed Fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract is for research, development, and production to support clinical trials for HIV vaccines. This work is being performed at Leidos Biomedical Research facilities in Frederick, Maryland. The contract does not have...